RNF149 modulates the type I IFN innate antiviral immune responses through degrading IRF3
PLOS Pathogens · 2025
DOI: 10.1371/journal.ppat.1013051 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Mengyun Wu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Interferon Regulatory Factor-3, Immunity, Innate, Interferon Type I. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Social Development Project of Jiangsu Province, Key Lab of Respiratory Disease of Suzhou.
Abstract (Originalsprache)
E3 ubiquitin ligases are key molecules in regulating the innate immune responses against virus. They catalyze the activation or degradation of various signaling proteins involved in the innate immune responses. Herein, we found the regulatory role of RNF149 in the host's innate immune responses against viral infection. Virus infection induced the expression of RNF149. Overexpression of RNF149 was associated with reduced production of IFN-β and enhanced viral replication. Mechanically, RNF149 interacted with IRF3 and downregulated its protein level. As an E3 ubiquitin ligase, RNF149 promoted the K27-linked ubiquitination of IRF3 at K409 and K33-linked ubiquitination at K366 and K409, which promoted IRF3 degradation through the proteasome pathway. Our results revealed the regulatory mechanism of RNF149 during viral infection and provided new insights into host cells responding to viral infection. Downregulating the expression of RNF149 may help enhance the antiviral ability of host cells and inhibit viral replication, thus providing a new strategy for the treatment of viral infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institutes of Biology and Medical Sciences, Soochow University, Suzhou, China.
- Department of Clinical Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Respiratory Medicine, Children's Hospital of Soochow University, Suzhou, China.
- The Fourth Affiliated Hospital, Institutes of Biology and Medical Science, SuZhou Medical College, Soochow University, Suzhou, China.
ORCID-Profile: Jinping Zhang
Förderung
- National Natural Science Foundation of China
- Social Development Project of Jiangsu Province
- Key Lab of Respiratory Disease of Suzhou
- Key Laboratory for Diagnosis and Treatment of Immune Diseases in Children
- Clinician scientist Project of Suzhou Medical College
Zitieren
APA
Wu, M., Cai, J., Qiao, G., Li, X., Zhou, J., Xu, F., Ye, Y., Wang, Y., Xu, X., Li, J., Tian, X., Shao, Y., Dong, C., Chen, Z., Hao, C., Yang, Y., & Zhang, J. (2025). RNF149 modulates the type I IFN innate antiviral immune responses through degrading IRF3. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013051
Vancouver
Wu M, Cai J, Qiao G, Li X, Zhou J, Xu F, et al. RNF149 modulates the type I IFN innate antiviral immune responses through degrading IRF3. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013051
BibTeX
@article{Wu2025,
author = {Wu, Mengyun and Cai, Jiamin and Qiao, Guodong and Li, Xiaoping and Zhou, Ji and Xu, Fei and Ye, Yunfei and Wang, Yufeng and Xu, Xuena and Li, Jiaoyang and Tian, Xiaoyu and Shao, Yu and Dong, Chunsheng and Chen, Zhengrong and Hao, Chuangli and Yang, Yi and Zhang, Jinping},
title = {RNF149 modulates the type I IFN innate antiviral immune responses through degrading IRF3},
journal = {PLOS Pathogens},
year = {2025},
doi = {10.1371/journal.ppat.1013051}
}
EUVIMED